219 related articles for article (PubMed ID: 8153668)
1. Immunotherapy of malignant gliomas.
Jaeckle KA
Semin Oncol; 1994 Apr; 21(2):249-59. PubMed ID: 8153668
[No Abstract] [Full Text] [Related]
2. T-cell immunotherapy for malignant glioma: toward a combined approach.
Dietrich PY; Dutoit V; Tran Thang NN; Walker PR
Curr Opin Oncol; 2010 Nov; 22(6):604-10. PubMed ID: 20739889
[TBL] [Abstract][Full Text] [Related]
3. [Cellular immunotherapy for malignant glioma].
Okamoto Y; Yamashita J
Nihon Rinsho; 2005 Sep; 63 Suppl 9():557-62. PubMed ID: 16201581
[No Abstract] [Full Text] [Related]
4. Monitoring immune responses after glioma vaccine immunotherapy.
Jian B; Yang I; Parsa AT
Neurosurg Clin N Am; 2010 Jan; 21(1):195-9. PubMed ID: 19944978
[TBL] [Abstract][Full Text] [Related]
5. Gliomas: new ways of treatment?
van Acker RE
Clin Neurol Neurosurg; 1977; 80(2):112-5. PubMed ID: 209922
[TBL] [Abstract][Full Text] [Related]
6. [Dendritic cell therapy for malignant glioma].
Yamanaka R; Homma J; Yajima N; Tsuchiya N; Tanaka R
No To Shinkei; 2003 Sep; 55(9):771-80. PubMed ID: 14571839
[TBL] [Abstract][Full Text] [Related]
7. Adoptive immunotherapy of CNS malignancies.
Plautz GE; Shu S
Cancer Chemother Biol Response Modif; 2001; 19():327-38. PubMed ID: 11686021
[TBL] [Abstract][Full Text] [Related]
8. Cell- and peptide-based immunotherapeutic approaches for glioma.
Yamanaka R
Trends Mol Med; 2008 May; 14(5):228-35. PubMed ID: 18403264
[TBL] [Abstract][Full Text] [Related]
9. [Peptide vaccination therapy for malignant glioma].
Yamanaka R; Itoh K
Brain Nerve; 2007 Mar; 59(3):251-61. PubMed ID: 17370651
[TBL] [Abstract][Full Text] [Related]
10. [Active immunotherapy of cerebral tumor. 20 cases].
Trouillas P; Lapras C
Neurochirurgie; 1970; 16(2):143-70. PubMed ID: 4317954
[No Abstract] [Full Text] [Related]
11. Autologous natural killer cell therapy for human recurrent malignant glioma.
Ishikawa E; Tsuboi K; Saijo K; Harada H; Takano S; Nose T; Ohno T
Anticancer Res; 2004; 24(3b):1861-71. PubMed ID: 15274367
[TBL] [Abstract][Full Text] [Related]
12. [A new experimental approach to the specific adoptive immunotherapy for malignant gliomas].
Yamasaki T
Nihon Geka Hokan; 1983 Nov; 52(6):783-801. PubMed ID: 6331809
[No Abstract] [Full Text] [Related]
13. Mechanisms of local immunoresistance in glioma.
Albesiano E; Han JE; Lim M
Neurosurg Clin N Am; 2010 Jan; 21(1):17-29. PubMed ID: 19944963
[TBL] [Abstract][Full Text] [Related]
14. Dendritic cell-based immunotherapy for malignant gliomas.
Akasaki Y; Black KL; Yu JS
Expert Rev Neurother; 2005 Jul; 5(4):497-508. PubMed ID: 16026233
[TBL] [Abstract][Full Text] [Related]
15. Cell-Based Immunotherapy of Gliomas.
Everson RG; Antonios JP; Liau LM
Prog Neurol Surg; 2018; 32():90-100. PubMed ID: 29990977
[TBL] [Abstract][Full Text] [Related]
16. Immunobiologic aspects of the brain and human gliomas. A review.
Wikstrand CJ; Bigner DD
Am J Pathol; 1980 Feb; 98(2):517-68. PubMed ID: 6986786
[No Abstract] [Full Text] [Related]
17. [Efficacy of experimental active specific immunotherapy and immunoprevention of malignant gliomas of the brain].
Romodanov SA; Zatula DG; Lisianyĭ NI; Glavatskiĭ AIa; Prosvirneva GM
Zh Vopr Neirokhir Im N N Burdenko; 1986; (3):18-23. PubMed ID: 3739492
[TBL] [Abstract][Full Text] [Related]
18. [Neurosurgery and molecular biology: (series 12) immunological therapy for gliomas].
Kijima H; Shimizu K
No Shinkei Geka; 1999 Dec; 27(12):1071-7. PubMed ID: 10629887
[No Abstract] [Full Text] [Related]
19. Immunogene therapy as a treatment for malignant brain tumors in young mice.
Glick RP; Lichtor T; Lin H; Tarlock K; Cohen EP
J Neurosurg; 2006 Jul; 105(1 Suppl):65-70. PubMed ID: 16871873
[TBL] [Abstract][Full Text] [Related]
20. Proceedings: Immunological investigations on human brain tumor patients.
Mahaley MS
Proc Natl Cancer Conf; 1972; 7():811-5. PubMed ID: 4358071
[No Abstract] [Full Text] [Related]
[Next] [New Search]
